drugset / Trial / NCT03767738
Study to Evaluate an Aflibercept (EYLEA®) Prefilled Syringe
NaSingle-groupOpen-labelTreatment
Summary
The primary objective of the study is to determine if the pre-filled syringe (PFS) supports successful preparation and accurate administration of an aflibercept injection. The secondary objective of the study is to assess ocular safety in the study eye.
Timeline
- Start
- 2018-12-19
- Primary completion
- 2020-08-19
- Completion
- 2020-08-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aflibercept | Protein / enzyme biologic | — | Intravitreal |